TERN-101 Uses, Dosage, Side Effects and more
TERN-101 is under investigation in clinical trial NCT04328077 (LIFT Study: A Safety, Tolerability, Efficacy, and Pharmacokinetics Study of TERN-101 in Subjects With Non-cirrhotic Non-alcoholic Steatohepatitis (NASH)).
| Trade Name | TERN-101 |
| Generic | TERN-101 |
| Type | |
| Formula | C28H27Cl2N3O4 |
| Weight | Average: 540.44 Monoisotopic: 539.1378618 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
